Systematic Investigation of Blacks With Stroke - GENOMICS

NCT05619406 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-11-16

No results posted yet for this study

Summary

The overall goal of SIBS-GENOMICS is to utilize the best available contextual data on stroke in Africa to develop \& validate stroke risk estimation models, translate the best model into a mobile phone app and conduct a randomized control trial of the app with a co-created motivational education video, to determine their effectiveness for improvement of stroke risk factor awareness and global risk reduction among Africans.

Conditions

Interventions

DEVICE

Riskometer Application

The intervention group participants at baseline will be assessed by installing a riskometer app on their mobile phones to calculate their global stroke risk score. They will be shown their risk scores and the specific risk factors identified through the screening. They will be counselled and supported to manage their risk factors through lifestyle changes and visit their healthcare provider for appropriate care.

BEHAVIORAL

Routine Clinic Therapy

After their assessment by the blinded adjudicator, the controls will visit the study doctor to obtain the routine clinic therapy and then will be allowed to go home.

Sponsors & Collaborators

  • Medical University of South Carolina

    collaborator OTHER
  • University of Ibadan

    collaborator OTHER
  • Federal Medical Centre, Abeokuta

    collaborator UNKNOWN
  • Ahmadu Bello University Teaching Hospital

    collaborator OTHER
  • Bayero University Kano, Nigeria

    collaborator OTHER
  • Kwame Nkrumah University of Science and Technology

    collaborator OTHER
  • Korle-Bu Teaching Hospital, Accra, Ghana

    collaborator OTHER
  • University of Alabama at Birmingham

    collaborator OTHER
  • University of Washington

    collaborator OTHER
  • University College Hospital, Ibadan

    lead OTHER

Principal Investigators

  • Mayowa O. Owolabi, MD · College of Medicine University of Ibadan

  • Bruce Ovbiagele, MD · University of California, San Francisco

  • Fred S. Sarfo, PhD · Kwame Nkrumah University of Science & Technology (KNUST)

  • Benjamin S. Aribisala, PhD · Lagos State University, (LASU)

  • Michelle Nichols, PhD · Medical University of South Carolina

  • Oyedunni S. Arulogun, PhD · University of Ibadan

  • Carolyn Jenkins, PhD · Medical University of South Carolina

  • Bukola Ajala, PhD · University of Ibadan

  • Onoja M. Akpa, PhD · University of Ibadan

  • Odun J. Akinyemi, PhD · University of Ibadan

  • Rufus A. Akinyemi, PhD · University of Ibadan

  • Reginald O. Obiako, PhD · Ahmadu Bello University Teaching Hospital, (ABUTH) Zaria

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-20
Primary Completion
2022-11-06
Completion
2022-12-15

Countries

  • Ghana
  • Nigeria

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05619406 on ClinicalTrials.gov